CHRONIC MYELOGENOUS LEUKEMIA (CML)
Clinical trials for CHRONIC MYELOGENOUS LEUKEMIA (CML) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOGENOUS LEUKEMIA (CML) trials appear
Sign up with your email to follow new studies for CHRONIC MYELOGENOUS LEUKEMIA (CML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One donor, two transplants: new hope for patients with blood cancer and kidney failure
Disease control CompletedThis study tested a combined bone marrow and kidney transplant from a partially matched family donor for 10 people with both a serious blood disorder and chronic kidney disease. The goal was to treat both conditions with one donor, potentially reducing the need for lifelong anti-…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA (CML)
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 17, 2026 03:01 UTC
-
Expanded cord blood cells show promise in speeding recovery for blood cancer patients
Disease control CompletedThis study tested a new cord blood product called NiCord, which is grown in a lab to have more stem cells, against standard cord blood transplants for people with blood cancers like leukemia and lymphoma. The goal was to see if NiCord helps the body rebuild its blood and immune s…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA (CML)
Phase: PHASE3 • Sponsor: Gamida Cell ltd • Aim: Disease control
Last updated May 15, 2026 11:53 UTC